Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial.
What is most important to patients with BCR prostate cancer? Metastasis-free versus treatment-free survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 May 16 [Epub ahead of print] David J Einstein, …